Engineering Papers⌕ Search

Engineering topics

Roy, Subhojit

Publications and source records attributed to Roy, Subhojit.

Dark Matter searches with photons at the LHC

We unveil blind spot regions in dark matter (DM) direct detection (DMDD), for weakly interacting massive particles with a mass around a few hundred GeV that may reveal interesting photon signals at the LHC. We explore a scenario where the DM primarily originates from the singlet sector within the Z 3 -symmetric Next-to-Minimal Supersymmetric Standard Model (NMSSM). A novel DMDD spin-independent blind spot condition is revealed for singlino-dominated DM, in cases where the mass parameters of the higgsino and the singlino-dominated lightest supersymmetric particle (LSP) exhibit opposite relative signs (i.e., κ < 0), emphasizing the role of nearby bino and higgsino-like states in tempering the singlino-dominated LSP. Additionally, proximate bino and/or higgsino states can act as co-annihilation partner(s) for singlino-dominated DM, ensuring agreement with the observed relic abundance of DM. Remarkably, in scenarios involving singlino-higgsino co-annihilation, higgsino-like neutralinos can distinctly favor radiative decay modes into the singlino-dominated LSP and a photon, as opposed to decays into leptons/hadrons. In exploring this region of parameter space within the singlino-higgsino compressed scenario, we study the signal associated with at least one relatively soft photon alongside a lepton, accompanied by substantial missing transverse energy (E T ) and a hard initial state radiation jet at the LHC. In the context of singlino-bino co-annihilation, the bino state, as the next-to-LSP, exhibits significant radiative decay into a soft photon and the LSP, enabling the possible exploration at the LHC through the triggering of this soft photon alongside large E T and relatively hard leptons/jets resulting from the decay of heavier higgsino-like states.

72 PHYSICS OF ELEMENTARY PARTICLES AND FIELDS↗

The NIH Somatic Cell Genome Editing program

The move from reading to writing the human genome offers new opportunities to improve human health. The United States National Institutes of Health (NIH) Somatic Cell Genome Editing (SCGE) Consortium aims to accelerate the development of safer and more-effective methods to edit the genomes of disease-relevant somatic cells in patients, even in tissues that are difficult to reach. Here we discuss the consortium’s plans to develop and benchmark approaches to induce and measure genome modifications, and to define downstream functional consequences of genome editing within human cells. Central to this effort is a rigorous and innovative approach that requires validation of the technology through third-party testing in small and large animals. New genome editors, delivery technologies and methods for tracking edited cells in vivo, as well as newly developed animal models and human biological systems, will be assembled—along with validated datasets—into an SCGE Toolkit, which will be disseminated widely to the biomedical research community. We visualize this toolkit—and the knowledge generated by its applications—as a means to accelerate the clinical development of new therapies for a wide range of conditions.

59 BASIC BIOLOGICAL SCIENCES↗